Cure Alzheimer's Fund Cure Alzheimer's Fund
  • Honoring Allison Jennings McCance
  • The Disease
    • Pathology
    • Signs & Symptoms
    • Risk Factors
    • Early Onset
    • Dementia
    • Women & Alzheimer’s
    • Detection
    • Stats & Costs
  • The Research
    • Areas of Focus
      • Alzheimer’s Genome Project
      • Genes to Therapy / Stem Cell Screening
      • Identification
      • Immune System Structures & Processes
      • Interaction of the Microbiome
      • Pathological Pathways & Systems
      • Therapeutic Strategies & Drug Discovery
      • Whole Genome Sequencing
      • Other Areas of Investigation
    • Consortia
      • ALZHEIMER’S DISEASE DRUG DISCOVERY & DEVELOPMENT (AD4)
      • FLEMING APOE
      • CIRCUITS
      • BRAIN ENTRY & EXIT
      • NEUROIMMUNE
    • Funded Projects
    • Grant Process
    • Our Researchers
    • Topics of Interest
      • Alzheimer’s in a Dish
      • Amyloid Hypothesis
      • Amyloid Precursor Protein
      • Brain Lymphatic System
      • Innate Immunity
      • Microglia
      • Blood Brain Barrier
    • Published Papers
    • Discoveries
  • About Us
    • Our Story
    • Our People
    • Reports
  • Giving
    • Donate
    • Ways to Donate
      • CRYPTOCURRENCY
      • Planned Giving
    • Our Heroes
    • In Memory & In Honor
    • Artists Giving Back
    • Charity Watchdogs
  • News and Events
    • Events
      • 2018 Symposium Video
    • Webinars
    • Interviews
    • Press
    • Videos
    • Research Newsletter
      • December 2021
      • Fall 2020
      • March 2020
      • November 2019
      • October 2019
      • July 2019
      • March 2019
      • January 2019
      • November 2018
    • Blog
  • Awareness
    • The Face of Alzheimer’s
    • Better Your Brain
    • World Alzheimer’s Day
    • Dr. Solomon Carter Fuller
  • Contact
  • Search
Cure Alzheimer's Fund Cure Alzheimer's Fund
  • 781-237-3800
  • Donate
  • Contact
  • Search

News and Events


Listed here are previous announcements and events regarding advances in Alzheimer's science, funding, and awareness.

CUREALZ

Events

Interviews

News

Press

Videos

Webinars


October 7 2022

BLOOD PRESSURE MEDICATION: A FUTURE TREATMENT FOR AD?

October 7 2022

ALTERING THE GUT MICROBIOME IMPACTS AMYLOID IN THE BRAIN

October 7 2022

IMPROVING A MALFUNCTIONING BRAIN DRAIN CLEARS AMYLOID PLAQUES

October 7 2022

IDENTIFIED: AN ELUSIVE TOXIN THAT DAMAGES NEURONS

October 7 2022

POTENTIAL DIAGNOSTIC TOOL: MEASURING NEUROINFLAMMATION IN THE BRAIN

October 7 2022

SOME BRAINS ARE RESILIENT TO ALZHEIMER’S

October 7 2022

A NEW DIAGNOSTIC TOOL: PET SCANS OF GAMMA-SECRETASE IN THE BRAIN

October 7 2022

GAMMA-SECRETASE MODULATORS FOR AD

October 7 2022

TREM2 ANTIBODIES REDUCE AD PATHOLOGY

October 7 2022

BENEFIT OF EXERCISE FOR COGNITIVE DECLINE

October 7 2022

A RARE VARIANT OF APOE3 REDUCES RISK OF DEVELOPING AD

October 7 2022

Women & Alzheimer’s: The ZBTB7C Gene

More

Register for email updates about our latest news:

© 2005 - 2023 Cure Alzheimer's Fund. All rights reserved.

Cure Alzheimer’s Fund is a “doing business as” name for the Alzheimer’s Disease Research Foundation, a 501(c)(3) public charity with federal tax ID #52-239-6428.

Privacy Policy

Donate | 100% goes directly to research

  • Contact
  • 781-237-3800
  • Sitemap